Medications for Sickle Cell Anemia

2 results

  • adakveo - crizanlizumab injection

    (Crizanlizumab)
    Novartis Pharmaceuticals Corporation
    Adakveo reduces the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease.
    Medication Details

  • casgevy

    (Exagamglogene Autotemcel)
    Vertex Pharmaceuticals Incorporated
    Casgevy is indicated for patients aged 12 and older with sickle cell disease (SCD) with recurrent vaso-occlusive crises, or transfusion-dependent β-thalassemia (TDT).
    Medication Details
    Drug Interactions